Best Life Sciences Companies in Kentucky, United States
The 91 best Life Sciences companies in Kentucky, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Kiniksa Pharmaceuticals.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Kentucky
| # | Company | Disclosed funding | Last round | Employees | Founder | Stage | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Kiniksa Pharmaceuticals Developer of therapeutics for multiple diseases treatment | $320M | 97 mo ago | 2 | Sanj Patel CEO | Public | DrupalApple iCloud MailPHP+35 | — | — |
| 2 | Talaris TX Developer of single-dose cell therapy | $215M | 68 mo ago | 129 | — | Public | — | 59 patents Automated coin handling: sorting, counting, validation, and cash transaction processing. | — |
| 3 | Apellis Pharmaceuticals Developer of therapeutics for the treatment of rare diseases | $213M | 73 mo ago | 451 451 → 594 (+32%) | Pascal Deschatelets Co-Founder | Acquired | DrupalApple iCloud MailMicrosoft 365+26 | 366 patents Long-acting compstatin-based complement inhibitors for ocular and systemic disease therapy | — |
| 4 | Xanodyne Pharmaceuticals Developer of drugs for women's health and pain management | $176M | 199 mo ago | 6 | — | Acqui-Hired | — | — | — |
| 5 | US World Meds Developer of therapeutics for the treatment of multiple diseases | $154M | 14 mo ago | 216 | — | Series B | JavaVue.jsAmazon Web Services+16 | — | — |
| 6 | ViaCord Provider of services for cord blood and stem cell banking | $84M | 269 mo ago | 98 | Cynthia Fisher Founder | Acquired | Cart FunctionalityDrupalPHP+36 | 7 patents Stem cell‑based therapies for CNS disorders and ischemic injury using cord‑blood pluripotent cells | — |
| 7 | Joerns Healthcare Manufacturer and distributor of of wound care, bariatric and safe patient handling equipment | $42M | 203 mo ago | 1,243 | — | Late Stage | — | 69 patents Adjustable-width therapeutic mattresses and dynamic patient support surface systems. | — |
| 8 | Nexeon MedSystems Bioelectronics company developing neurostimulation devices and software for remote patient management | $28M | 106 mo ago | 48 | — | Deadpooled | — | 58 patents Patents concentrated in health & consumer products | — |
| 9 | Avaxia Biologics Developing orally-delivered antibody therapeutics for GI diseases. | $25M | 131 mo ago | 11 | — | Series B | — | 52 patents Oral antibody therapeutics targeting TNF for gastrointestinal inflammatory diseases | — |
| 10 | Naprogenix Screening and identification of plant compounds for pharmaceuticals and agrochemicals. | $14M | 14 mo ago | 4 | Deane Falcone Co-Founder | Funding Raised | — | 2 patents Engineering plant pathways to produce selective estrogen receptor modulators and other metabolites | — |
| 11 | Bexion Pharmaceuticals Formulation of a synthetically produced, human lysosomal protein for the potential treatment of glioblastoma. | $13M | 152 mo ago | 48 | — | Funding Raised | — | — | — |
| 12 | ParaTechs Corporation Biotechnology company developing innovative technologies for research and development in biotechnology areas | $10M | 14 mo ago | 4 | — | Funding Raised | — | — | — |
| 13 | Advanced Cancer Therapeutics Developer of DNA Aptamers and small molecule therapeutics for cancer | $10M | 165 mo ago | 1 | Randy Riggs President & CEO | Series A | — | — | — |
| 14 | Vivorte Developer of bone grafting and regenerative products for orthopedic treatment | $9M | 47 mo ago | 4 | — | Series A | — | 11 patents Injectable bone graft compositions and processed bone particle systems for orthopedic regeneration | — |
| 15 | Neuronetrix Cognitive testing and analysis systems for neurological diseases | $9M | 100 mo ago | 5 | KC Fadem CEO | Series A | — | 62 patents Electrophysiological diagnostic devices integrating biomarkers for neuromuscular disorder testing | — |
| 16 | Bioptics Technology Developer of fluorescence imaging devices and cerebral blood flow monitoring systems | $7M | 9 mo ago | — | Cindy Sun Founder & CEO | Funding Raised | — | — | — |
| 17 | NX PharmaGen Personalized medicine through next-generation molecular diagnostics and imaging technologies | $7M | 44 mo ago | 3 | Brian Brohman Co-Founder & CEO | Seed | — | 14 patents Extracellular vesicle and protein biomarkers for cancer and preterm birth diagnostics | — |
| 18 | Gismo Therapeutics Biotech developing innovative oral therapeutics for Alzheimer's and Parkinson's Disease | $6M | 103 mo ago | — | Paul Gregor Founder & CEO | Funding Raised | — | — | — |
| 19 | NX Prenatal Provider of early warning blood tests for pregnancy complications | $6M | 34 mo ago | 6 | Brian Brohman Co-Founder & Co-CEO | Series A | — | 44 patents Prenatal biomarker analysis and AI-driven prediction of pregnancy complications (e.g., preeclampsia). | — |
| 20 | 3P Biotechnologies Developer of exosome extraction technique | $5M | 10 mo ago | — | Ramesh Gupta Founder & President | Funding Raised | — | 122 patents Targeted oral/gum pocket delivery systems and mucosal immunotherapeutics | — |
| 21 | Advanced Genomic Technology Developer of blood-based test for diagnosis and prognosis of Alzheimer’s disease and metastatic ovarian cancer | $5M | 146 mo ago | — | Eugenia Wang Founder & CEO | Funding Raised | — | — | — |
| 22 | Aquisense Provider of UV-C LED based disinfection system 60Product top 26%Growth top 28%Talent top 28%Patents top 36% All 10 signals ▾Producttop 26% Growthtop 28% Talenttop 28% Patentstop 36% Innovationtop 37% Techtop 37% Fundingtop 42% Moattop 45% Globalbottom 35% Marketbottom 33% Product: 7 distinct product lines · Company stage: Acquired Growth: Web rank 10,000,000 → 5,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 60/100 | $4M | 3 mo ago | 26 | — | Acquired | WordPressMySQLPHP+33 | 12 patents UV-LED based water and liquid disinfection and purification systems | — |
| 23 | Nexosome Oncology Developer of a platform for diagnosis of cancer | $4M | 53 mo ago | — | Ken Dicken Co-Founder | Seed | — | — | — |
| 24 | Sword Performance Developer of supplements for health and wellness | $4M | 31 mo ago | 11 | Shawn Stasko Founder | Seed | ShopifyAnimate.cssBootstrap+22 | — | — |
| 25 | Bluegrass Advanced Materials Antioxidant polymers based therapy for the treatment of oral mucositis | $4M | 14 mo ago | 2 | Thomas Dziubla Co-Founder | Funding Raised | — | — | — |
| 26 | RhinoCyte Diesel generator sets supplier, covering production, sales, maintenance, and integrated services | $4M | 128 mo ago | — | Fred Roisen Co-Founder | Deadpooled | — | — | — |
| 27 | Hera Biolabs Provider of rodent models for in vitro and in vivo safety and efficacy testing services | $3M | 70 mo ago | 15 | — | Acquired | — | — | — |
| 28 | EndoProtech Developer of liposome-based therapies for myocardial infarction and alcohol liver disease | $3M | 203 mo ago | 4 | — | Funding Raised | — | 9 patents Therapeutic agents for microvascular dysfunction and related vascular disease treatments. | — |
| 29 | NX Development Corporation Provider of intra-operative imaging tools to visualize tumors | $3M | 120 mo ago | — | Salvatore Desena President & Chief Executive Officer | Acquired | — | — | — |
| 30 | Hummingbird Nano Manufacturer of microfluidic chips | $2M | 41 mo ago | 10 | Grant Stephens CEO | Seed | — | — | — |
| 31 | Pradama pharmaceuticals Drugs for bone diseases and disorders | $1M | 199 mo ago | — | William Pierce Ex-President & CEO | Deadpooled | — | — | — |
| 32 | Vindico Pharmaceuticals Specialty company focused on developing therapeutic products using nanotechnology | $1M | 135 mo ago | — | Eric Ostertag CEO | Deadpooled | — | — | — |
| 33 | NaugaNeedles Manufacturer of SPM probes, nanoneedles, and micro-fabrication services | $1M | 184 mo ago | 5 | Mohammad YazdanPanah Founder & CEO | Funding Raised | — | 4 patents Micro‑fabricated needle array platforms for biomedical sample handling and nano‑electronics interconnects. | — |
| 34 | MobileMedTek Mobile medical device | $1M | 123 mo ago | 10 | Bryan Ehret Founder & CFO | Deadpooled | — | 11 patents Electrophysiological measurement devices and testing kits for medical diagnostics | — |
| 35 | Surna Cultivation Technologies Indoor agriculture equipment, engineering, and services for controlled environment facilities | $1M | 56 mo ago | 39 | Brandy Keen Co-Founder | Public | WordPressMySQLPHP+30 | — | — |
| 36 | Intralink-Spine Developer of device for treating spinal disc degeneration | $1M | 114 mo ago | 2 | Tom Hedman Founder | Acqui-Hired | — | — | — |
| 37 | DesiCorp Developer of freeze-dried blood product for blood transfusion | $1M | 3 mo ago | 4 | Jonathan Kopechek Co-Founder | Series A | — | 3 patents Adjustable loading devices for handling agricultural products | — |
| 38 | Protibea Therapeutics Developer of immune therapies for neurological and immune-mediated diseases | $970K | 10 mo ago | — | William Chamberlin Co-Founder | Seed | — | — | — |
| 39 | Intrepid Bio Online gaming platform offering diverse betting options and secure transactions | $875K | 178 mo ago | 3 | — | Deadpooled | — | — | — |
| 40 | Cardinal Spine Inter body fusion devices designed to stabilise spinal implants | $748K | 114 mo ago | — | Natasha Lonnon Founder | Acqui-Hired | — | — | — |
| 41 | MedPro Passive needle stick prevention technology | $727K | 164 mo ago | 15 | Craig Turner Founder & ex-CEO | Public | — | 5 patents On-site pharmaceutical potency/purity analysis and integrated patient‑restraint mattress systems | — |
| 42 | LBIdx Developer of blood plasma analyzer for disease detection and therapy monitoring | $625K | 190 mo ago | — | Alfred Jenson Co-Founder | Funding Raised | — | — | — |
| 43 | InFlaMed Developer of proprietary therapeutics for neuroinflammatory brain disorders | $552K | 24 mo ago | — | Jianhua Zhou Founder & CEO | Funding Raised | — | — | — |
| 44 | Cobra Stylet Guide for intubation | $517K | 165 mo ago | — | Francis Duque Co-Founder | Seed | — | 4 patents Airway intubation devices for tracheal tube placement | — |
| 45 | Magna Pharmaceuticals Pharmaceutical company specializing in safe, effective, and affordable health products | $499K | 145 mo ago | 7 | Warren Lesser CEO & President | Early Stage | Wix eCommerceCart FunctionalityWix+20 | — | — |
| 46 | Omega Ophthalmics Developer of intraocular lens for the treatment of a cataract | $450K | 5 mo ago | — | Rick Ifland CEO | Seed | — | 166 patents Intraocular lens capsular bag prosthetic devices for cataract surgery | — |
| 47 | Solidagex Manufacturing and marketing natural extracts derived from goldenrod plant | $315K | 149 mo ago | — | David McClure Founder | Deadpooled | — | — | — |
| 48 | Endoscopy Assist Devices Manufacturer of endoscopic medical devices for improved patient outcomes | $206K | 84 mo ago | — | Anthony Appling Co-Founder | Funding Raised | — | — | — |
| 49 | Fawkes Biotechnology Developer of identification and treatment of concussions | $198K | 98 mo ago | — | Tamara Jovonovich Co-CEO | Funding Raised | — | — | — |
| 50 | PharmassetX Developer of a small molecule drug targeting chronic inflammatory diseases | $150K | 1 mo ago | — | David McClure Co-Founder & COO | Seed | — | — | — |
Top 12 Life Sciences companies in Kentucky
#1
Series B · Louisville, Kentucky · founded 2001 · 216 employees$154.4Mraised▾
Developer of therapeutics for the treatment of multiple diseases. The company's drugs include APOKYN (apomorphine hydrochloride injection for Parkinson's disease), CORGARD (nadolol tablets for hypertension, angina pectoris), MYOBLOC (rimabotulinumtoxinB Injection for cervical dystonia), REVONTO (dantrolene sodium injection for anesthetic-induced malignant hyperthermia syndrome) and XADAGO (safinamide tablets for Parkinson's Disease).
- Apr 2025Grant (prize money)$2.9M
- Mar 2025Grant (prize money)$2.9M
- May 2007Series B$55.5M
- Nov 2006Series B$85M
#2
Acquired · Erlanger, Kentucky · founded 2015 · 26 employees$4.1Mraised▾
Provider of UV-C LED-based disinfection system. It offers disinfection systems that can work in water, air, and surface. It provides energy management solutions for residential buildings, commercial, transportation, and others.
- Mar 2026Series A$1.6M
- Mar 2025Series A$2.5M
- Seed—
#3
Funding Raised · Lexington, Kentucky · founded 2019$7.2Mraised▾
Developer of fluorescence imaging devices and cerebral blood flow monitoring systems. It designs and builds products that advance medical research. Its offerings include a wearable eye-loupe based fluorescence imaging device for imaging visible dyes, a non-contact tool for 2D/3D imaging of cerebral blood flow and oxygenation, and a wearable diffuse speckle contrast flow-oximetry probe for continuous cerebral blood flow and oxygen saturation monitoring.
- Aug 2025Grant (prize money)$2M
- Mar 2025Grant (prize money)$2.1M
- Sep 2023Grant (prize money)$1M
- Aug 2023Grant (prize money)$1.2M
#4
Series A · Louisville, Kentucky · founded 2017 · 4 employees$1Mraised▾
Developer of freeze-dried blood product for blood transfusion. The company is developing freeze-dried red blood cells that can be stored and infused to patients experiencing traumatic blood loss, especially in remote or battlefield settings.
- Mar 2026Series A$840K
- Jul 2024Series A$5.2M
- Feb 2023Grant (prize money)$281.9K
#5
Funding Raised · Louisville, Kentucky · founded 2013$5.1Mraised▾
3P Biotechnologies has developed the patented technology for exosome extraction from bovine milk and colostrum. The platform also developing a uterine cervical implant device called PolyC. This device helps in the continuous local release of drugs in cervical cancer disease. The platform also extracted the drug called ANTHOS from the biberry extracts.
- Aug 2025Grant (prize money)$506.5K
- Mar 2025Grant (prize money)$506.5K
- Sep 2024Grant (prize money)$500K
- Sep 2024Grant (prize money)$506.5K
#6
Funding Raised · Lexington, Kentucky · founded 2002 · 4 employees$14.1Mraised▾
Naprogenix, Inc., a biotechnology company, provides pharmacological screens to access and screen for plant compounds which can be used for leads for pharmaceuticals and agrochemicals.The company uses its proprietary technology which involves transformation of plant cell, mutagenesis of candidate plant species, identification of the desired tramsformed and mutagenesised cell, followed by isolating extracts, screening and identifying the candidate plant compound. Naprogenix announced the spin off of Solidagex, a new company to commercialize plant beneficial compounds identified from goldenrod based products using its proprietary technology. Naprogenix intends to follow a similar commercialization plan for other products that are identified in wild type plant extracts in its library.
- Apr 2025Grant (prize money)$3.9M
- Sep 2018Grant (prize money)$2.1M
- Nov 2016Grant (prize money)$286K
- Sep 2016Grant (prize money)$456K
#7
Funding Raised · Lexington, Kentucky · founded 2004 · 4 employees$10.4Mraised▾
Biotechnology company developing innovative technologies for research and development in biotechnology areas. They focus on creating novel products to enable advancements in the field. Their offerings include assisted reproductive technology (ART) products for rodents, protein expression products, and a nitrate reductor kit. They are involved in contract research services and seek partnering opportunities through commercial licensing and collaborative research and development. The company's mission is centered around providing solutions for researchers, with a focus on rodent assisted reproduction. They offer devices for non-surgical embryo transfer, artificial insemination, embryo vitrification, and sperm cryopreservation. They also provide technologies for improving recombinant protein production. Their products are intended for research purposes only and not for therapeutic or diagnostic use.
- Apr 2025Grant (prize money)$236.1K
- 2023Grant (prize money)$236.1K
- 2022Grant (prize money)$258.9K
- 2019Grant (prize money)$225K
#8
Seed · Louisville, Kentucky · founded 2024$150Kraised▾
Developer of a small molecule drug targeting chronic inflammatory diseases. The company's lead asset is an FDA-designated orphan drug intended to address an unmet need. The company focuses on developing therapeutics for inflammatory bowel disease, viral and infectious diseases, metabolic and cardiovascular diseases, neuro-degenerative diseases, and autoimmune diseases. The leadership team has experience in healthcare and life sciences.
- Apr 2026Seed$100K
- Sep 2025Seed$50K
#9
Seed · Lexington, Kentucky · founded 2012$450Kraised▾
Developer of intraocular lens for the treatment of a cataract. The company has developed a proprietary lens known as "Omega Gemini Refractive Capsule" that propels cataract surgery to improve visual rehabilitation.
- Jan 2026Seed$320K
- Dec 2024Seed$250K
- Jul 2022Seed$450K
#10
Funding Raised · Lexington, Kentucky · founded 2013 · 2 employees$3.6Mraised▾
Bluegrass Advanced Materials is developing naturally derived antioxidant polymers for applications in various biotech industries. The company is currently developing an oral treatment for oral inflammation and ulceration (Oral Mucositis) associated with the adverse effects of chemo and radiation therapies.
- Apr 2025Grant (prize money)$1.2M
- Sep 2020Grant (prize money)$746.6K
- Sep 2017Grant (prize money)$169.3K
- Sep 2013Grant (prize money)$1.6M
#11
Seed · Georgetown, Kentucky · founded 2018$970Kraised▾
Developer of immune therapies for neurological and immune-mediated diseases. It offers a r lead product is 16-alpha bromoepiandrosterone which is a water miscible synthetic steroid hormone that influences biological pathways affecting signaling cascades of the immune system for the treatment of Alzheimers disease.
- Jul 2025Seed$200K
- May 2021Seed$770K
#12
Acquired · Crestwood, Kentucky · founded 2008 · 451 employees$213.2Mraised▾
Developer of therapeutics for the treatment of rare diseases. The company is developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system. The company develops programs across ophthalmology, nephrology, hematology, and neurology.
- May 2020Post IPO$328.9M
- Sep 2019Post IPO$220M
- Aug 2017Series E$60M
- 2017Series E—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
What Kentucky researches in biotechnology
Kentucky's University of Kentucky and peers research plant-microbe immunity, CRISPR, and insect genetics with a cautiously optimistic tone, balancing breakthroughs against notable concerns.
- University of Kentucky18
- Western Kentucky University1
- Kentucky State University1
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.